Skip to content

Clinical trials

Anxiety Disorders trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Not applicable Country / region: China Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20103
20111
20121
20143
20151
20174
20182
20193
20204
202110
202212
202318
202425
202522
202628

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Unknown status29
Recruiting26
Not yet recruiting20
Active, not recruiting9
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University9
Nanjing Medical University5
Shenyang Medical College5
Adai Technology (Beijing) Co., Ltd.4
Chinese PLA General Hospital4
Jiangsu Province Nanjing Brain Hospital4
Shanghai Mental Health Center4
Shanghai University of Traditional Chinese Medicine4
Anhui Medical University3
Central South University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders139
Sleep Initiation and Maintenance Disorders9
Pain5
Breast Neoplasms4
Stress Disorders, Post-Traumatic4
Alzheimer Disease3
COVID-193
Cognitive Dysfunction3
Depressive Disorder3
Coronary Disease2

Trials

Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.